Experienced in Rubella

Dr. Stephen R. Walsh

Infectious Disease
Brigham and Women’s Hospital
Dana-Farber Cancer Institute, Center For Hematologic Oncology
450 Brookline Avenue, 
Boston, MA 
Experienced in Rubella
Brigham and Women’s Hospital
Dana-Farber Cancer Institute, Center For Hematologic Oncology
450 Brookline Avenue, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Stephen Walsh is an Infectious Disease provider in Boston, Massachusetts. Dr. Walsh is rated as an Experienced provider by MediFind in the treatment of Rubella. His top areas of expertise are HIV/AIDS, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Togaviridae Disease.

His clinical research consists of co-authoring 98 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Rubella.

Graduate Institution
McGill University, 1994 - 1998
Residency
Boston Medical Center (BMC), 1998 - 2001
Specialties
Infectious Disease
Licenses
Internal Medicine in MA
Board Certifications
Infectious Disease
Fellowships
Brigham and Women's Hospital, 2001 - 2004
Hospital Affiliations
Brigham And Women's Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Tufts
  • HMO

Locations

Dana-Farber Cancer Institute, Center for Hematologic Oncology
450 Brookline Avenue, Boston, MA 02115
Call: 617-732-8881

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)
Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)
Enrollment Status: Completed
Publish Date: November 20, 2024
Intervention Type: Drug
Study Drug: Ibrexafungerp
Study Phase: Phase 3
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Polyvalent Env (A,B,C,A/E) / Gag (C) DNA and gp120 (A,B,C,A/E) Protein HIV-1 Vaccines (PDPHV-201401) Co-administered With or Without Adjuvant GLA-SE in Repeated Doses, in Healthy, HIV-1 Uninfected Adult Participants
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Polyvalent Env (A,B,C,A/E) / Gag (C) DNA and gp120 (A,B,C,A/E) Protein HIV-1 Vaccines (PDPHV-201401) Co-administered With or Without Adjuvant GLA-SE in Repeated Doses, in Healthy, HIV-1 Uninfected Adult Participants
Enrollment Status: Completed
Publish Date: April 09, 2024
Intervention Type: Biological
Study Drugs: env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant
Study Phase: Phase 1
A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of an Accelerated Vaccination Schedule With a Zika Virus Purified Inactivated Vaccine Plus Alum Adjuvant in Healthy Adults
A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of an Accelerated Vaccination Schedule With a Zika Virus Purified Inactivated Vaccine Plus Alum Adjuvant in Healthy Adults
Enrollment Status: Completed
Publish Date: August 23, 2018
Intervention Type: Other, Biological
Study Phase: Phase 1
View 2 Less Clinical Trials

98 Total Publications

Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challenge.
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challenge.
Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025
View All 98 Publications
Similar Doctors
Advanced in Rubella
Dr. Emily P. Hyle
Infectious Disease
Advanced in Rubella
Dr. Emily P. Hyle
Infectious Disease

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
 (2.7 miles away)
617-724-0287
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Emily Hyle is an Infectious Disease provider in Boston, Massachusetts. Dr. Hyle is rated as an Advanced provider by MediFind in the treatment of Rubella. Her top areas of expertise are HIV/AIDS, Measles, Togaviridae Disease, and Mumps. Dr. Hyle is currently accepting new patients.

Rochelle P. Walensky
Experienced in Rubella
Dr. Rochelle P. Walensky
Infectious Disease
Experienced in Rubella
Dr. Rochelle P. Walensky
Infectious Disease

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
 (2.7 miles away)
617-724-0287
Languages Spoken:
English
See accepted insurances

Rochelle Walensky is an Infectious Disease provider in Boston, Massachusetts. Dr. Walensky is rated as a Distinguished provider by MediFind in the treatment of Rubella. Her top areas of expertise are HIV/AIDS, Mumps, Togaviridae Disease, and Severe Acute Respiratory Syndrome (SARS).

Experienced in Rubella
Dr. Edward T. Ryan
Infectious Disease
Experienced in Rubella
Dr. Edward T. Ryan
Infectious Disease

Massachusetts General Physicians Organization Inc

55 Fruit St, 
Boston, MA 
 (2.7 miles away)
617-724-0287
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Edward Ryan is an Infectious Disease provider in Boston, Massachusetts. Dr. Ryan is rated as a Distinguished provider by MediFind in the treatment of Rubella. His top areas of expertise are Cholera, Typhoid Fever, Salmonella Enterocolitis, and Shigellosis. Dr. Ryan is currently accepting new patients.

VIEW MORE RUBELLA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Walsh's expertise for a condition
ConditionClose
      • Advanced
      • HIV/AIDS
        Dr. Walsh is
        Advanced
        . Learn about HIV/AIDS.
        See more HIV/AIDS experts
      • Severe Acute Respiratory Syndrome (SARS)
        Dr. Walsh is
        Advanced
        . Learn about Severe Acute Respiratory Syndrome (SARS).
        See more Severe Acute Respiratory Syndrome (SARS) experts
      • Experienced
      • COVID-19
        Dr. Walsh is
        Experienced
        . Learn about COVID-19.
        See more COVID-19 experts
      • Mumps
        Dr. Walsh is
        Experienced
        . Learn about Mumps.
        See more Mumps experts
      • Parainfluenza
        Dr. Walsh is
        Experienced
        . Learn about Parainfluenza.
        See more Parainfluenza experts
      • Rubella
        Dr. Walsh is
        Experienced
        . Learn about Rubella.
        See more Rubella experts
      • Sepsis
        Dr. Walsh is
        Experienced
        . Learn about Sepsis.
        See more Sepsis experts
      • Togaviridae Disease
        Dr. Walsh is
        Experienced
        . Learn about Togaviridae Disease.
        See more Togaviridae Disease experts
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.